22 May 2013
Keywords: melacine, plus, intron, trial, track, ribi, immunochem
Article | 26 March 1998
Ribi ImmunoChem Research has reported that the first interim review ofdata from its pivotal Phase III study of Melacine, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.